This analysis models vaccine effectiveness in SARS-CoV-2 variants, suggesting reliable estimates despite limited data.
Both proposed approaches produced similar VE estimates to those from well-known methods. The VPM could also provide VE estimates when the validation techniques were limited by low sample size.
No takes yet. Share an insight, caveat, or question.
Antunes et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: